Community‐based rapid HIV testing in homeless and marginally housed adults in San Francisco
- 15 January 2007
- journal article
- Published by Wiley in HIV Medicine
- Vol. 8 (1) , 28-31
- https://doi.org/10.1111/j.1468-1293.2007.00423.x
Abstract
Standard two-step HIV testing is limited by poor return-for-results rates and misses high-risk individuals who do not access conventional testing facilities. We describe a community-based rapid HIV testing programme in which homeless and marginally housed adults recruited from shelters, free meal programmes and single room occupancy hotels in San Francisco received OraQuick Rapid HIV-1 Antibody testing (OraSure Technologies, Bethlehem, PA, USA). Over 8 months, 1614 adults were invited to participate and 1213 (75.2%) underwent testing. HIV seroprevalence was 15.4% (187 of 1213 individuals) overall and 3.5% (37 of 1063) amongst high-risk individuals reporting no previous testing, a prior negative test, or previous testing without result disclosure. All 1213 participants received their results. Of 30 newly diagnosed persons who received confirmatory results, 26 (86.7%) reported at least one contact with a primary healthcare provider in the 6 months following diagnosis. We conclude that community-based rapid testing is feasible, acceptable and effective based on the numbers of high-risk persons tested over a short period, the participation rate, the prevalence of new infection, the rate of result disclosure, and the proportion linked to care.Keywords
This publication has 4 references indexed in Scilit:
- Rapid HIV Testing of Clients of a Mobile STD/HIV ClinicAIDS Patient Care and STDs, 2005
- HIV Seroprevalence Among Homeless and Marginally Housed Adults in San FranciscoAmerican Journal of Public Health, 2004
- Failure to Return for HIV Test Results Among Persons at High Risk for HIV InfectionJAIDS Journal of Acquired Immune Deficiency Syndromes, 2004
- Voluntary Counseling, Testing, and Referral for HIV: New Technologies, Research Findings Create Dynamic OpportunitiesJAIDS Journal of Acquired Immune Deficiency Syndromes, 2000